Buy & Sell Bristol-Myers Squibb Co (BMY) – Bristol-Myers Squibb Co Price Today
Aura AI Summary
Key Stats
- $121.14BMarket Cap
- HealthSector
- -8.61%3M Drawdown
- $157.60BEnterprise Value
- 4.25%Dividend Yield
- 92 daysTypical Hold Time
Bristol-Myers Squibb Co (BMY) is currently valued at a market capitalization of $121.14B, with an enterprise value of $157.60B. Over the past 52 weeks, Bristol-Myers Squibb Co has traded between a low of $42.6 and a high of $62.37, highlighting its annual price range. Over the past three months, Bristol-Myers Squibb Co has recorded a drawdown of -8.61%, reflecting recent price volatility. Bristol-Myers Squibb Co offers a dividend yield of 4.25%, with the most recent dividend of $0.63 paid on 02 Apr 26. On average, investors hold Bristol-Myers Squibb Co for approximately 92 days, indicating typical investor behavior on the platform.
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
